THE MAGNIFICENT TECH JUNE 5th SELL-OFF
The latest earnings season underscored the importance of the AI pillar. The biggest names in the S&P 500 are the market’s version of “Extraordinary Gentlemen,” at least from an earnings standpoint. The ten largest companies in the S&P 500 now account for roughly 34% of the index’s total profits. That is double what it was in 1996. The most recent earnings from the Magnificent Tech companies exceeded the other 493 S&P 500 stocks by more than 40%. We haven’t seen that since 2014.
Not surprisingly, earnings concentration shakes investor confidence. It is the anthesis of diversification. Think of it as the difference between holding a diversified nest egg versus holding one egg and watching it very carefully.
The market is clearly aligning with the latter strategy. Recent earnings reinforce the reality that AI demand is compounding at an exponential rate, and the surge in industry‑wide capital spending underscores that we are still in the early innings of this cycle. In that light, concentration is less problematic and more a tolerable feature.
There will inevitably be outsized declines, as we saw on June 5th when profit‑taking in the market’s biggest year‑to‑date winners triggered the Nasdaq’s sharpest sell‑off since the April 2025 tariff‑driven rout under Trump. Episodes like this are a feature of a market led by a narrow group of high‑momentum names. When investors decide to take chips off the table, the unwind is fast, deep, and highly concentrated.
According to press reports the sell-off was triggered by a better-than-expected employment report which flipped the rate-cut narrative. The probability of a rate hike before year end rose from 50% to 75% at the time of writing.
The bond market reacted immediately, as the yield on 10-year Treasury Notes jumped above 4.5%. Rising yields make government bonds more attractive relative to growth stocks and increase borrowing costs for companies building AI infrastructure which partially explains why traders transitioned from growth stocks to value plays.
That said, we believe the technology sector can withstand the headwinds associated with 4.5% yields, but a move above 5% would likely lead to a change in sentiment. Which is why we remain laser focused on trends in the fixed income space.
That explanation, while poignant, is only part of the story. We understand the relationship between borrowing costs and the infrastructure spend, but that only partly explains the cause and effect associated with the June 5th downturn. We think some of the fallout can be explained by investors selling winners to raise cash to buy into the June 12th SpaceX IPO.
That may seem like a stretch but AI bellwethers like Nvidia, AMD, and Micron, dropped between 3% and 12% on the day. After months of relentless AI‑driven gains, these names had been priced for perfection and had grown into oversized positions across institutional portfolios. That made them natural sources of liquidity, which made them ideal candidates to harvest profits and free up cash ahead of the highly anticipated SpaceX IPO.
AI MEGA‑CYCLE INTACT, BUT WITH MORE VOLATILITY
The tech sell-off in early June did not, in our opinion, alter the AI investment cycle. The recent volatility appears to be more about re-balancing and rotation then a change in mindset.
The AI mega‑cycle remains the dominant structural force in global markets, shaping capital expenditure, corporate strategy, and equity leadership across sectors. But the narrative is evolving. What was once a broad, “rising tide lifting all AI‑adjacent assets,” is now becoming more selective, more volatile, and more sensitive to macro economic conditions.
This shift is not a sign that the AI boom is ending. Rather, it marks the transition from the euphoria phase to the execution phase where fundamentals, capital efficiency, and real revenue generation matter more than sentiment.
Investors are beginning to differentiate between companies that are building the infrastructure of the AI economy, those that are successfully deploying AI into scalable applications, and those that merely invoke AI as a marketing tool without meaningful financial impact. And there lies the rub! If we are to manage in this altered universe it is essential to separate the success stories from the also rans.
The AI Cycle Is Still the Center of Gravity
Despite the early June variability, the AI cycle continues to dominate global capital flows. Hyper-scalers which are the largest buyers of compute capacity continue to increase their Cap-Ex budgets at extraordinary rates. The world’s largest cloud providers are collectively on track to spend multi-trillions of dollars for data centers, GPUs, networking equipment, and power infrastructure over the next several years. This is unprecedented in scale and speed.
Semiconductor demand remains robust as it provides the power for AI training workloads, inference at scale, building out enterprise applications and AI deployment for end-users.
Enterprise adoption is already accelerating. Companies across industries from finance to manufacturing to healthcare, are integrating AI into workflows, customer service, logistics, and product development. The productivity gains are real, even if unevenly distributed.
In that sense, the AI cycle is not a bubble in the traditional sense. It is a long‑duration investment wave reshaping the global economy. But like all major transitions, it will not move in a straight line. Bluntly speaking, AI investment is no longer a free lunch.
For most of 2023 through 2025, AI stocks benefited from a powerful combination of narrative momentum, earnings upside, and abundant liquidity. Valuations expanded dramatically, especially among semiconductor leaders and AI‑exposed mega-cap tech stocks. There was a time when investors were willing to pay almost any price for exposure to the theme. That era is ending.
The June 5th sell‑off was a reminder that macro shocks matter. When Treasury yields spike, it increases the discount rate applied to future earnings and AI centric businesses with their long‑duration cash flow profiles, feel the impact disproportionately. Inflation surprises, geopolitical tensions, and shifts in Fed expectations now have the power to trigger sharp, sudden reversals in the sector.
This is not a sign of structural weakness. It is simply the reality of a maturing investment cycle. As valuations rise, sensitivity to macro-economic conditions intensify. The higher the expectations, the narrower the margin for error. What we are witnessing is that investors are becoming more selective and are no longer willing to pay for “AI exposure.” They are paying for AI execution and are demanding evidence.
One of the clearest signs of a maturing cycle is the emergence of tiered performance within the AI ecosystem. The market is no longer treating all AI‑related companies as equals. Instead, it is drawing sharper distinctions between three categories: 1) AI infrastructure, 2) AI application and 3) AI pretenders.
AI infrastructure winners will be the companies that build the physical and digital backbone of the AI economy. Think in terms of semiconductor manufacturers, GPU and accelerator designers, data center operators, high performance network providers and power and cooling infrastructure specialists. Companies like Nvidia, Intel Corporation, Samsung Electronics and Micron Technology are leaders in the infrastructure space, while companies like Amazon Web Services, Microsoft Azure and Google Cloud provide AI specific compute tiers.
These firms benefit from the sheer scale of AI compute demand. Their revenue growth is tied to tangible, measurable investment cycles. They are the “picks and shovels” of the AI gold rush, and they remain the most reliable beneficiaries of the mega‑cycle.
However, even these leaders are not immune to volatility. When yields rise or Cap-Ex expectations shift, infrastructure names can experience sharp drawdowns. But their long‑term demand profile remains the strongest in the ecosystem.
Companies involved in AI applications are one step above the infrastructure. These are the companies that build the AI enterprise tools, develop AI-enhanced productivity software and deliver vertical-specific AI solutions and consumer applications. Open AI, Anthropic, Amazon AWS, Microsoft Copilot and interestingly, IBM will be major players in the enterprise build out.
This group is more diverse and more sensitive to execution risk. Some firms are successfully converting AI capabilities into recurring revenue and margin expansion. Think Meta, Google and Amazon. Others are still in the experimentation phase.
The winners in this category will be those that can demonstrate clear return on investment for customers, can deploy at scale, are able to integrate AI into existing workflows and know how to develop customer loyalty by converting usage into consistent revenue streams. On the one hand, this is where the next wave of AI‑driven earnings surprises will likely emerge, but this is also the sector where the most dispersion will occur.
The pretenders are the companies that over-promise and under-deliver. Think about earnings calls where executives talk about AI without tying it to meaningful revenue enhancement. Watch for companies that rebrand products as “AI-powered,” or talk up their pursuit of AI initiatives that sound more like marketing hype than real progress. In the early phase of the cycle, these companies benefited from fear-of-missing-out (FOMO) enthusiasm. But as investors become more discerning, the market is punishing firms that cannot demonstrate real traction.
Summary
The AI mega‑cycle is not ending, it is normalizing. We think the next phase will be defined by greater sensitivity to macro conditions, higher variability around earnings, greater differentiation between winners and losers, and more focus on capital efficiency and its impact on future revenue.
This is the natural evolution of any transformative technology cycle. The Internet went through it. Cloud computing went through it. Smartphones went through it. AI is now entering its own version of the “prove it” phase. In our view, this is not a call for caution, it is a call for discipline. The long-term opportunity remains intact, but the phase of early returns is past. The next leg of the AI rally will require proof not momentum.
RISK MULTIPLICITY
Is it just me or are the financial markets doing their best impression of Spiderman climbing the proverbial “wall of worry.” Dodging the bullets and taking the arrows, marching ever higher. What’s odd is that the market appears to be ignoring multiple stressors including;
Treasury Market Fragility: Hedge funds have amassed US $1.5 trillion in leveraged-based trades which rely on stable Treasury markets and cheap financing. Liquidity strain could destabilize the system.
Market Concentration & AI Risk: Equity markets are dominated by a handful of mega-cap AI-driven companies. If investors begin questioning AI’s ability to meet or exceed the market’s lofty expectations, a stampede to unwind positions could trigger margin calls, hit retirement portfolios, and crush global risk sentiment.
Geopolitical Stressors: The Iran war is disrupting supply chains, raising energy prices and lowering global growth. Russia’s escalating “shadow war” with Europe adds further instability. U.S. political dysfunction is increasingly being compared to emerging market dynamics.
Warsh Loyalty: A new Fed chair surrounded by the perception of questionable loyalties. Imagine the reaction from bond vigilantes should newly appointed Fed Chair Kevin Warsh convince the FOMC to cut rates prematurely.
IPO Surge: An unprecedented surge in initial public offerings (IPOs): SpaceX is set to go public on June 12th with an estimated valuation of US ~ $1.8 Trillion which would make Elon Musk the world’s first Trillionaire. Anthropic and Open AI will likely hit markets before year end, with a combined valuation of ~ US $1.9 Trillion in private markets. Hard to look at these IPOs and not think that the markets are a little frothy.
Despite persistent macro headwinds, financial markets continue to set new record highs. It’s no surprise, then, that some observers are drawing parallels to the first nine months of 1987, where we witnessed a period of relentless gains that ultimately ended with the October 19th collapse known as “Black Monday.”
We would argue, however, that today’s backdrop is fundamentally different. The 1987 surge was supported by strong underlying economic fundamentals: the easing of Cold War tensions, the momentum toward German reunification, and a wave of deregulation anchored in President Reagan’s supply side economic agenda. The current rally, by contrast, is unfolding against a far more mixed macro landscape, making the comparison more superficial than substantive.
The lynchpin that exacerbated the Black Monday sell-off was a protective market strategy called portfolio insurance. The idea was to buy or sell securities based on ex-post moves in the equity market. When the selling began, portfolio insurance algorithms would continue selling unabated. The lack of human intervention caused markets to continue declining despite economic fundamentals.
Another historical signpost that has gained a following is the similarity between AI and the Internet euphoria that dominated the 1990s under President Clinton. That eight-year surge in markets ended when the Internet bubble burst at the turn of the century. It took the US equity market four years to recover from that calamity before finally finding its’ footing.
Again, there are differences. The Internet craze was dominated by startups that were not profitable, Amazon, for example, was generating record setting losses. Smaller companies collapsed under the weight of unsustainable debt.
In the current environment, the massive spending on brick-and-mortar data centers is coming from profitable hyper-scalers that see AI as the next evolution of the Internet. Moreover, these companies are already seeing their revenues increase and margins improve from significant AI induced layoffs and user uptake.
The result is stronger than expected GDP growth and low unemployment – particularly in the US – backstopped by a business-friendly regulatory environment and the considerable stimulus that is coming from the private sector.
It’s notable that spending on the AI data center build-out is expected to contribute as much as 20% to U.S. GDP. That is not surprising, as private sector stimulus, not subject to the friction that impinges government spending, delivers about four times the impact.
Think about this in terms of the Democrats twin stimulus packages known as the Inflation Reduction Act and the CHIPs Act. Those stimulus packages added more than US $2.3 trillion in economic stimulus. The current AI expenditure comes in about the same amount over three years and is expected to continue for the foreseeable future. Keeping with the 4 to 1 leverage thesis, AI spending equates to as much as US $8.6 trillion in economic activity.
The real risk will come if AI does not deliver the profit potential that hyper-scalers have been touting. Which is to say, today’s valuations hinge on whether investors believe what the hyper-scalers are saying. If we see evidence that profits from AI do not match the vision, then all bets are off. And there is the conundrum… we won’t really know until it’s too late!
To that point, any signs that AI is not the panacea that we all think will only be visible two or three years from now. In the interim, like the roller coaster approaching the apex, either enjoy the ride, or don’t ride the roller-coaster.
The early signs of risk mitigation will come from the bond market, which dwarfs the equity markets in terms of its size. Which brings us back to one of the risk metrics cited earlier. If the Fed decides to cut rates, bond vigilantes will likely push up mid and long-term rates as they will demand higher yields to compensate for the inflation risk associated with premature rate cuts. Much will depend on where the new Fed Chair’s loyalties land… what’s best for the economy or what’s desired by President Trump.
The other concern comes back to the multiplicity of risk thesis. Unlike traditional risk management that assigns a probability to any one factor, the multiplicity thesis recognizes feedback loops, where stress in one factor accelerates stress in another.
From our perspective, any serious sell-off will not be the result of any one threat, but rather a combination of stressors cited above. Fortunately, risk multiplicity does not occur in a vacuum. It manifests slowly where momentum accelerates like a snowball rolling down a mountain where the fallout can be serious.
Putting a pin on this, we find ourselves caught between the proverbial rock and a hard place. Coping with bullish expectations propelled by FOMO against the risk of being tossed from a bucking bull.
Investment Strategy
In an environment facing multiple risks the most appropriate investment strategy is to anchor client portfolios in “Resilient Core” Assets. The objective is to build a foundation that survives a multitude of outcomes.
This so-called “Resilient Core” typically includes blue chip value-based companies paying above-average dividends. Think about companies in defensive industries that have pricing power and robust balance sheets. These stocks may not shoot the lights out, but they will anchor the portfolio’s equity exposure. Canadian banks, Pipelines (i.e.; Enbridge Inc.), big name Pharmaceuticals and Utilities would provide some of the requisite stability.
Low‑volatility equity strategies also play a role. Think in terms of systematic option‑overlays where the premium income from the sale of covered calls provides cashflow to the portfolio along with some downside protection. When markets are facing risk multiplicity, income is the ballast.
Short‑duration bonds or Treasury Bills protect against rate volatility and provide optionality if long rates spike due to bond vigilantes.
This works because you’re not betting on a single macro-outcome. You’re building a chassis that handles both acceleration and sudden braking.
Once the portfolio is sufficiently anchored, look for opportunities. Recognize, for example, that the AI bona-fides are genuine, that the spending is real, that the profit curve is murky and that financial markets are pricing perfection.
This is not the setup to make an outsized bet. AI should be treated as a “Growth Sleeve,” not the portfolio’s foundation. We want to have exposure to AI, but will size it like a venture bet. Enough to participate in upside, not enough to sink the ship.
Focus on the picks-and-shovels layer which includes infrastructure, power, chips and data centers. The parts of the stack that get paid regardless of which model wins. Finally, you should opt for diversified exposure over single-name concentration. Risk is not related to failure; it is that the profit pool ends up smaller or more concentrated than expected.
This allows our portfolios to capture the structural growth trend without tying your fate to the most optimistic assumptions.
OIL HOLDS NEAR $100 AS TENSIONS PERSIST
From a global macro-economic perspective, oil is again in the spotlight. Not because demand is growing or supply is breaking, but because of geopolitics. The US–Iran conflict is keeping a risk premium under crude and adding stress to an already complicated macro environment. And while the economic impact is manageable for now… the takeaway is unmistakable: the world is running on fumes with less margin for error.
 |  |
Both West Texas Intermediate Crude (WTI) and Brent Crude have been range bound between US $80 and US $115 since the beginning of the Iran conflict. While these levels are not catastrophic, they remain uncomfortably high and are likely to go much higher based on news sources reporting that oil executives have warned President Trump that things could get much worse before they get better.
Energy prices feed into transportation, manufacturing, logistics, food, and ultimately consumer sentiment. When oil hovers near triple digits, it acts as a tax on households and a drag on discretionary spending. It feeds into inflation which is harder to manage when the US labor market is running hot.
This is why the current moment matters. Markets are priced for perfection or at a minimum, a smooth glide path toward disinflation and stable growth. But geopolitics rarely respects market narratives. The combination of sticky inflation, tight labor conditions, and geopolitical risk is a recipe for volatility, especially when valuations across equities remain elevated and investor positioning is tilted toward risk assets.
A Conflict That Won’t Go Away
The US-Iran conflict is not new, but its latest escalation has added fresh uncertainty. The Middle East remains the world’s most strategically important energy corridor, and even the perception of instability can move markets. Although neither side appears intent on triggering a full-scale regional crisis, recurring clashes, retaliatory strikes, and diplomatic breakdowns have kept a geopolitical risk premium in crude prices.
This premium is not about immediate supply disruptions since global inventories remain acceptable, and OPEC+ has not signaled any emergency measures. Instead, it reflects the market’s recognition that the probability of a more serious disruption, however small, is no longer negligible. When oil traders price risk, they price probabilities, not certainties.
The result is a market that trades with a geopolitical floor. Every time tensions flare, crude spikes. Every time diplomacy cools, prices ease. But, not enough to break below the new baseline. We think this dynamic will persist through the summer.
Energy’s Impact on Inflation
For central banks, energy is the most frustrating inflation component. It is volatile, globally determined, and largely outside the control of domestic policy. The Federal Reserve cannot drill more oil, negotiate peace agreements, or influence OPEC+ production targets. Yet energy prices feed directly into headline inflation and indirectly into core inflation through transportation and input costs.
The Fed has spent the past two years trying to engineer a soft landing by cooling inflation without crushing growth. But high oil prices complicate that calculus. If crude remains elevated into Q3, the disinflation process could stall. Headline inflation may re‑accelerate. Core inflation could become sticky again and that could influence consumers take on inflation which the Fed closely monitors.
This is why the June and July inflation prints will be critical. If energy remains near current levels, the Fed may find itself in a position where it must maintain a hawkish stance even as growth moderates. That is not a comfortable place for markets.
The Consumer Squeeze
High oil prices act like a regressive tax. It hits lower‑income households hardest, because a larger share of their spending goes toward transportation and energy. Even for middle‑income consumers, sustained high fuel costs reduce discretionary spending which is the lifeblood of the US economy.
The timing is also critical. After two years of elevated inflation, household savings buffers have thinned. Credit card balances are at record highs. Delinquencies are rising. Wage growth remains solid, but real purchasing power is not expanding as quickly as it did post Covid.
If gasoline prices rise meaningfully above US $4 per gallon nationally, which is likely if crude breaks above US $105, then consumer sentiment could deteriorate rapidly. Historically, consumer confidence has shown a strong inverse correlation with gasoline prices. When fuel becomes expensive, households pull back.
What makes this period different (we hate saying that by the way), is the so-called K-shaped environment. Upper middle-class Americans and Canadians with healthy stock portfolios are flush. Which is to say, higher gas prices are more a nuisance, than a problem.
The Dilemma: Growth vs. Inflation vs. Geopolitics
Central banks are navigating a complex macro environment. The US has a robust labor market (Canada’s labor market is not robust but it is better than expected), with unemployment near multi‑year lows. Conversely, inflation has not fully returned to target, and the path forward is uncertain.
High oil prices force the Fed into a defensive posture. Even if the central bank believes inflation will eventually cool, it cannot risk appearing complacent. As mentioned, markets have already repriced the probability of a rate hike later in 2026, and the Fed will not want to validate the perception that it is behind the curve.
This creates a delicate balancing act. If central banks are too hawkish, any tightening could lead to a slowdown. Too dovish and central banks risk reigniting inflation. If geopolitics worsens, there is a risk that Central banks will lose control of the narrative entirely.
In this environment, communication becomes as important as policy. Every press conference, every speech, every dot‑plot revision will be scrutinized for clues about how the Fed is interpreting the energy shock.
Markets Priced for Perfection
The critical point is that markets cannot effectively price geopolitical stress. Equity valuations remain elevated. Credit spreads are tight. Volatility is low. Investors have embraced the AI‑driven growth narrative and largely discounted macro risks.
But oil near US $100 is a reminder that the world is not as stable as asset prices imply. When markets are priced for perfection, even small shocks can trigger outsized reactions. A geopolitical flare‑up, an inflation surprise, or a hawkish shift from the Fed could all serve as catalysts for volatility. This does not mean a downturn is inevitable. But it does mean the margin for error is shrinking.
The Bottom Line
Oil’s climb toward US $100 is not just a commodity story, it is a macro story, a geopolitical story, and ultimately a market‑pricing story. The US–Iran conflict has introduced a persistent risk premium that is unlikely to fade quickly. High energy prices threaten to slow disinflation, squeeze consumers, and complicate the Fed’s policy path. And with markets priced for a smooth landing, any disruption to the narrative could heighten volatility.
The next few months will test the resilience of both the economy and investor sentiment. Energy is once again the wildcard and this time it is playing a central role in shaping the macro landscape.
BIOTECH BREAKOUTS AND THE GLP‑1 ARMS RACE
Few sectors have delivered as much excitement or as many outsized stock moves in 2026 as biotechnology. While AI and semiconductors dominate the headlines, biotech has quietly become one of the most explosive pockets of the market, driven by breakthrough clinical data, accelerating innovation cycles, and a surge of investor interest in metabolic health. At the center of this momentum is the GLP‑1 revolution, a once‑in‑a‑generation shift in how the world approaches obesity, diabetes, and metabolic disease.
The latest catalyst came from Eli Lilly’s oral GLP‑1 candidate which delivered strong Phase 2-B results, reinforcing the company’s leadership in a category that has already reshaped the pharmaceutical landscape. But the implications extend far beyond pharma.
The GLP‑1 wave is now influencing consumer behavior, corporate strategy, and industry economics across food, retail, insurance, and medical devices. What began as a drug story is rapidly becoming a multi‑industry disruption narrative that investors can no longer afford to ignore.
To understand why GLP‑1 drugs have become the hottest trade in healthcare, it’s important to appreciate the scale of the problem they address. Obesity affects more than 40% of adult Americans. Type 2 diabetes affects over 37 million Americans and the economic burden from healthcare costs to lost productivity, is measured in the hundreds of billions annually.
GLP‑1 was originally developed for diabetes but has since demonstrated unprecedented efficacy in weight loss. Drugs like semaglutide and tirzepatide have delivered double‑digit percentage reductions in body weight, reshaping expectations for what medical intervention can achieve. New oral solutions have dramatically altered the landscape. GLP-1 in pill form is easier to administer, more accessible, and potentially cheaper.
Eli Lilly’s recent Phase 2-B success signals that the GLP‑1 category is far from mature. Instead, it is entering a new phase of innovation, competition, and market expansion. The addressable market is enormous, and the demand is global.
Markets Are Paying Attention
Biotech stocks are notoriously volatile, but the GLP‑1 theme has provided a rare combination of scientific credibility, commercial traction, and investor enthusiasm. Several unique factors drive Biotech valuations.
Successful clinical trials engender an instant market reaction. Investors understand that even incremental improvements such as better tolerability, easier dosing, and faster uptake, can translate into billions in revenue.
With GLP-1 drugs investors see a clear path to commercialization. Whereas many biotech innovations face long regulatory timelines or uncertain reimbursement, GLP‑1 drugs have established demand, strong physician adoption with real world outcomes. This holy grail triad reduces uncertainty and increases valuation multiples. Note that Eli Lilly has recently become a member of the Trillion-dollar club.
In the biotech field, competition can enhance valuations. While Eli Lilly and Novo Nordisk dominate today’s GLP-1 market, dozens of large and early-stage biotech firms are racing to develop next‑generation metabolic therapies. This competition fuels innovation and creates a steady stream of catalysts.
Then there is the broader investment theme at play here. GLP‑1 drugs are not just about weight loss. They are being tested for cardiovascular risk reduction, liver disease, sleep apnea, kidney disease, additional and compulsive behaviors. Each new indication expands the market and strengthens the long‑term narrative.
As with AI deployment, there are ripple effects that are reshaping industries beyond biotech. This is not just a pharmaceutical story. It is a consumer‑behavior story, a corporate‑strategy story, and ultimately a macroeconomic story.
Early data suggests that GLP‑1 users consume fewer calories, less sugar, less alcohol, smaller meal portions. This has profound implications for packaged food companies, fast‑food chains, snack manufacturers and beverage producers.
We are already seeing companies acknowledging this trend in earnings calls. Others are quietly reformulating products or exploring “GLP‑1‑friendly” offerings. The shift won’t happen overnight, but the direction is clear: a healthier consumer is a different consumer.
Weight loss at scale also affects clothing sizes, fitness spending, beauty and wellness categories. There are noticeable changes in purchasing patterns, with increased demand for activewear and wellness products. The companies that adapt quickly may benefit from a multi‑year tailwind or face extinction from a once in a lifetime headwind.
Another less obvious insight is the impact GLP-1 drugs are having on the insurance industry. What we are witnessing is a reset of the Cost‑Benefit Equation.
GLP‑1 drugs are expensive, but the long‑term savings from reduced obesity‑related complications could be enormous. Some insurers have begun expanding coverage, while others remain cautious. The question insurers face; is it cheaper to pay for GLP‑1 drugs now or pay for chronic disease later? As more real‑world data emerges, expect insurers to shift toward broader coverage, especially if oral formulations reduce costs.
GLP-1 may also negatively impact the medical device industry. Weight loss reduces the need for CPAP machines, bariatric surgery, insulin pumps and glucose monitors. This is already showing up in device‑maker earnings. Companies tied to obesity‑related conditions face structural headwinds, while those aligned with wellness and metabolic monitoring are finding new opportunities.
Summary
The GLP‑1 revolution is one of the most important secular themes in global markets today. It sits at the intersection of healthcare innovation, consumer behavior, insurance economics, public health and corporate strategy.
Unlike many thematic trends, GLP-1 is backed by strong clinical data, real‑world adoption, clear regulatory pathways and massive addressable markets
This is why biotech stocks tied to metabolic health have delivered some of the year’s biggest gains and why the theme is likely to remain a core focus for years to come.
The most compelling aspect of the GLP‑1 narrative is its breadth. Few innovations ripple across so many sectors simultaneously. The last comparable disruption was arguably the smartphone that reshaped industries far beyond its original domain.
GLP‑1 drugs are doing something similar. They are changing how people eat, shop, exercise, sleep, and manage their health. They are forcing companies to rethink product lines, pricing strategies, and long‑term planning. They are influencing public policy and insurance design. And they are creating new winners and losers across the market. In short, the GLP‑1 revolution is reshaping consumer behavior and entire industries.
It is not hyperbole. It is a fair description of one of the most powerful forces in today’s market. And it is still in the early stages. The Biotech breakout year is not a coincidence, it is the result of a structural shift in how the world approaches metabolic health.
Eli Lilly’s latest data is just one milestone in a much larger transformation. As innovation accelerates and adoption expands, the GLP‑1 category will continue to influence markets far beyond healthcare. This is not a fad. It is a multi‑year, multi‑industry disruption cycle.
BITCOIN BREAKS
Bitcoin’s slide below US $60,000 which notably, was the first time it slide below that level since 2024, marking a significant moment for the digital‑asset market. Not because the level itself is magical, but because of what the move reveals about the underlying forces shaping crypto in 2026. The asset class remains highly sensitive to macro conditions, especially real yields, and the latest downturn underscores how tightly Bitcoin is now integrated into the broader financial system.
The decline was not driven by a single catalyst. Instead, it reflected a confluence of pressures: rising Treasury yields, a shift toward risk‑off sentiment, and ETF outflows that reversed months of steady inflows. Crypto‑linked equities miners (note: it costs upwards of US $80,000 to mine one bitcoin), exchanges, and blockchain infrastructure firms fell 6% to 11% in sympathy, highlighting how correlated the ecosystem has become.
This is not the speculative, isolated crypto market of 2017 or 2021. Bitcoin now trades like a macro asset, and its break below US $60K is a reminder that the digital‑asset cycle is increasingly governed by the same forces that move equities, bonds, and commodities.
The most important driver of Bitcoin’s decline is the surge in real yields (i.e., inflation‑adjusted interest rates) which have climbed sharply following stronger‑than‑expected US economic data. When real yields rise, the opportunity cost of holding non‑yielding assets increases. This dynamic affects gold, growth stocks, and crypto alike.
Bitcoin has long been marketed as “digital gold,” but in practice, it behaves more like a high‑beta macro asset. When yields rise, Bitcoin tends to fall. When liquidity expands, Bitcoin rallies. The June decline fits this pattern perfectly.
The market’s repricing of the Fed’s interest rate path (note the rising probability of an interest rate hike before the end of 2026) has tightened financial conditions. Bitcoin, which thrives in loose‑liquidity environments, is adjusting accordingly.
The broader market tone has become more cautious. The June 5th tech sell‑off, partially triggered by a hot jobs report and a spike in Treasury yields, spilled over into crypto. Investors who had been aggressively positioned in risk assets began reducing exposure across the board.
Crypto is often the first asset class investors sell when sentiment shifts. It is liquid, it trades 24/7, and it is held disproportionately by retail investors and hedge funds. These are groups that tend to react quickly to macro shocks. The result is a synchronized de‑risking:
One of the most important developments in the crypto market over the past two years has been the rise of spot Bitcoin ETFs, which have brought institutional capital into the asset class at unprecedented scale. These ETFs helped drive Bitcoin’s rally to new highs in 2025 and early 2026.
But ETFs are a double‑edged sword. They provide easy access for inflows and equally, easy access for outflows. In the days leading up to Bitcoin’s break below US $60K, ETF flows turned negative. Investors pulled capital from spot Bitcoin funds, reversing months of steady inflows. These outflows amplified the downside pressure, especially during periods of thin liquidity.
ETF flows have become one of the most important indicators for Bitcoin’s short‑term direction. When flows are positive, Bitcoin tends to rise. When flows turn negative, the market weakens. The mid-year decline is a textbook example of this dynamic.
The sell‑off has also extended beyond Bitcoin itself. Miners were hit particularly hard as their revenues are directly tied to Bitcoin’s price, and their cost structure which is propelled by energy costs have been rising. When Bitcoin falls, miner margins compress quickly making them some of the highest‑beta assets in the entire market.
Exchanges also felt the impact. Lower prices often lead to lower trading volumes, which reduces fee revenue. Companies like Robin Hood and Coinbase suffer valuation shocks. Blockchain infrastructure companies, which depend on network activity and token valuations, experienced similar declines.
The equity market’s reaction reinforces a key point: crypto is no longer a niche asset class. It is deeply integrated into public markets, and its volatility now affects and is affected by the same dynamics that impact traditional equities.
What the Break Below US $60K Means for Companies Leveraged to Bitcoin
As Bitcoin continues its slide, companies like Strategy Inc. are impacted exponentially. Strategy Inc. is uniquely leveraged to Bitcoin’s price which affects its ability to earn staking[1] revenue and dramatically impacts its balance sheet.
Strategy Inc. is a publicly traded Bitcoin proxy. Its core software business is profitable but small. The company’s equity value is overwhelmingly driven by the market value of its Bitcoin holdings. Strategy Inc. treats its’ Bitcoin holdings in the same way traditional businesses use Treasury securities.
Traders have played Strategy Inc. as a leveraged proxy for Bitcoin (for the record Strategy Inc.’s Crypto holdings have a cost base around US $69K per Bitcoin). Which is to say, Strategy Inc.’s stock price is fueled by a combination of Bitcoin x Leverage x Sentiment. When Bitcoin falls below a major psychological level like US $60K, all three of those factors move against the stock.
Strategy Inc. is succumbing to the pressure of marking its Bitcoin holdings daily. The company holds approximately 200,000 Bitcoins (based on the latest filings) so a drop below $60K has a meaningful impact on its balance sheet. Using the current holding, a US $5,000 decline in the price of Bitcoin reduces the value on the company’s balance sheet by US 1 billion.
This hit to the balance sheet does not impact earnings but it does affect the company’s book value, Loan-to-value ratios and investor perception of solvency. Strategy Inc. issued convertible debt and secured loans to buy Bitcoin. Lower Bitcoin prices increase the perceived risk of those liabilities.
The impact on Strategy’s stock price is palpable. The company’s shareholder base is dominated Hedge funds, momentum traders, Quant funds, Crypto-thematic investors which are the precise groups that react most violently when risk-off sentiment increases.
Strategy’s executive chairman is Michael Saylor who is one of the world’s most vocal Bitcoin advocates. He is unwaveringly bullish and would normally buy Bitcoin when the price dips. But because of his current leverage, he was forced to sell 20 Bitcoins to meet interest payments on his convertible debt. That did not play well among the Bitcoin crowd and caused even greater angst within his shareholder base. That said, Strategy did rause additional funds to buy-the-dip which occurred during the second week of June.
Still, we believe Saylor and his company are experiencing the market’s version of death by a thousand cuts.
Richard N Croft
[1] Bitcoin staking,” it refers to indirect, off‑chain methods of earning yield on BTC, such as: lending BTC to third‑party platforms, using wrapped or synthetic BTC on other blockchains, participating in external protocols that pay rewards for providing liquidity or collateral